Antimicrobial agents

被引:23
作者
Bush, K [1 ]
机构
[1] RW Johnson Pharmaceut Res Inst, Raritan, NJ 08869 USA
关键词
D O I
10.1016/S1367-5931(97)80006-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Antimicrobial agents active against multi-resistant Gram-positive bacteria are considered to be of major commercial potential. Commercially viable agents that have been included in recent successful trials include the streptogramins, novel glycopeptides, oxazolidinones and potent quinolones. Cationic peptides have generated much interest, but their utility as successful drug candidates remains questionable. Novel compound classes for possible exploitation include non-beta-lactam beta-lactamase inhibitors, inhibitors of lipid A biosynthesis and tRNA synthetase inhibitors. (C) Current Biology Ltd ISSN 1367-5931.
引用
收藏
页码:169 / 175
页数:7
相关论文
共 56 条
[1]  
AERESTRUP FM, 1996, ANTIMICROB AGENTS CH, V40, P1938
[2]  
AGOURIDAS C, 1996, 3 INT C MACR AZ STRE
[3]   Inhibition of peptidoglycan biosynthesis in vancomycin-susceptible and -resistant bacteria by a semisynthetic glycopeptide antibiotic [J].
Allen, NE ;
Hobbes, JN ;
Nicas, TI .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (10) :2356-2362
[4]   Molecular interactions of a semisynthetic glycopeptide antibiotic with D-alanyl-D-alanine and D-alanyl-D-lactate residues [J].
Allen, NE ;
LeTourneau, DL ;
Hobbs, JN .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (01) :66-71
[5]   Distribution of genes encoding resistance to streptogramin A and related compounds among staphylococci resistant to these antibiotics [J].
Allignet, J ;
Aubert, S ;
Morvan, A ;
ElSolh, N .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (11) :2523-2528
[6]   Glycylcyclines bind to the high-affinity tetracycline ribosomal binding site and evade Tet(M)- and Tet(O)-mediated ribosomal protection [J].
Bergeron, J ;
Ammirati, M ;
Danley, D ;
James, L ;
Norcia, M ;
Retsema, J ;
Strick, CA ;
Su, WG ;
Sutcliffe, J ;
Wondrack, L .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (09) :2226-2228
[7]   Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant Gram-positive bacterial infections [J].
Brickner, SJ ;
Hutchinson, DK ;
Barbachyn, MR ;
Manninen, PR ;
Ulanowicz, DA ;
Garmon, SA ;
Grega, KC ;
Hendges, SK ;
Toops, DS ;
Ford, CW ;
Zurenko, GE .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (03) :673-679
[8]   The chemistry of pseudomonic acid .17. Dual-action C-1 oxazole derivatives of pseudomonic acid having an extended spectrum of antibacterial activity [J].
Broom, NJP ;
Cassels, R ;
Cheng, HY ;
Elder, JS ;
Hannan, PCT ;
Masson, N ;
OHanlon, PJ ;
Pope, A ;
Wilson, JM .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (18) :3596-3600
[9]   Activities of the glycylcyclines N,N-dimethylglycylamido-minocycline and N,N-dimethylglycylamido-6-demethyl-6-deoxytetracycline against Nocardia spp and tetracycline-resistant isolates of rapidly growing mycobacteria [J].
Brown, BA ;
Wallace, RJ ;
Onyi, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (04) :874-878
[10]   Quinupristin-dalfopristin [J].
Bryson, HM ;
Spencer, CM .
DRUGS, 1996, 52 (03) :406-415